The mechanisms underlying cuproptosis are elucidated, myosin heavy-chain 9 (MYH9) is established as an executioner, and a treatment strategy for drug-resistant tumors is proposed.
Abstract
Cuproptosis is a recently identified form of copper-dependent cell death implicated in various physiological and pathological processes. However, the executive proteins involved and the role of physiological intracellular copper in cuproptosis remain unclear. Herein, we identified myosin heavy-chain 9 (MYH9) as a cuproptosis executioner. Copper binding induced MYH9 polymerization, which disrupted the actin cytoskeleton and led to cuproptotic cell death. Hexyl 2-(3,4,5-trihydroxy-phenyl) acetate (HThPA) was shown to induce cuproptosis by binding to the nuclear receptor Nur77, leading to depletion of copper chelate glutathione (GSH) and release of free copper from intracellular copper stores. Acetylation of MYH9 by acetyltransferase dihydrolipoamide S-acetyltransferase (DLAT) facilitated copper binding, regardless of its extracellular or intracellular origin. Physiological copper levels were higher in drug-resistant tumor cells and clinical samples, which increased the likelihood of HThPA-induced cuproptosis. These results elucidate the mechanisms underlying cuproptosis, establish MYH9 as an executioner, and propose a treatment strategy for drug-resistant tumors.
Cuproptosis is a form of programmed cell death reported in 2022, characterized by copper ions directly binding to mitochondrial lipoylated proteins, inducing aberrant protein aggregation and destabilizing iron-sulfur cluster proteins, ultimately leading to cell death. Distinct from apoptosis, ferroptosis, and other kno...
Peng-Peng Li, Yang-Yang Gao, Wei Liu· Frontiers in Cell and Develo...· 0 citations
Systemic and intracellular copper homeostasis is described, including intestinal absorption, intracellular trafficking, mitochondrial copper distribution, storage, and export, and the molecular basis of cuproptosis is discussed, including the roles of FDX1, FDXR, LIAS, DLAT, mitochondrial respiration, protein lipoylati...
R. Eshraghi, N. Hosseini, M. Yazdani et al.· Apoptosis· 0 citations
The cuproptosis-immunity intersection remains at an early stage; key mechanistic findings require independent validation before clinical translation and core controversies regarding the universality of cuproptosis immunogenicity, the immune activation window of copper ions, and the clinical utility of cuproptosis bioma...
Xiang-Xiang Ren, Tian-Hao Xie, Xiao-Shi Jin et al.· Frontiers in Immunology· 0 citations
Cuproptosis is a recently identified form of regulated cell death. It is primarily driven by abnormal mitochondrial copper accumulation. Ferredoxin 1-dependent copper reduction promotes the pathological aggregation of lipoylated proteins involved in the tricarboxylic acid cycle and the loss of iron-sulfur cluster prote...
Xin-Yi Zhang, Ru-Fan Xu, Hong-Rui Zhang et al.· Brain Research Bulletin· 0 citations
This review summarizes current understanding of the molecular mechanisms governing cuproptosis and ferroptosis and identifies unresolved questions concerning pathway specificity, temporal regulation, biomarker validation, and the clinical safety of systemic or prolonged therapeutic modulation.
Yuan-Yuan Li, F. Tay· Signal Transduction and Targ...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.